Arrow Mark Colorado Holdings LLC Nuvalent, Inc. Transaction History
Arrow Mark Colorado Holdings LLC
- $6.65 Billion
- Q4 2024
A detailed history of Arrow Mark Colorado Holdings LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, Arrow Mark Colorado Holdings LLC holds 295,350 shares of NUVL stock, worth $23.5 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
295,350
Previous 295,152
0.07%
Holding current value
$23.5 Million
Previous $30.2 Million
23.43%
% of portfolio
0.35%
Previous 0.43%
Shares
8 transactions
Others Institutions Holding NUVL
# of Institutions
231Shares Held
58.9MCall Options Held
834KPut Options Held
490K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.43 Billion34.87% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.36MShares$426 Million16.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.5MShares$358 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$240 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.62MShares$208 Million6.84% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.42B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...